Total amount: € 0,00
Indexed/Abstracted in: EMBASE, Scopus, Emerging Sources Citation Index
Online ISSN 1827-1782
Siani A., Intrieri F., Fazzini S., Marino M., Irace L.
Aim. The aim of this study is to evaluate the safety and efficacy of the ProCol vascular bioprosthesis as vascular access material.
Methods. From January 2002 to January 2005, 22 arteriovenous bovine vein grafts (ProCol) were placed in 22 hemodialysis patients as vascualr access. In 15 cases we performed a bridge grafts between brachial artery and axillary vein with straight configuartion, in 7 cases between axillary artery and vein with loop configuration.
Results. Graft placement was successful in all patients, with no procedure related complications. No patients were lost at follow-up. The follow-up from 6-24 months showed a primary patency rates of 95.2%, 80.9%, 71.4% at 6,12 and 24 months. In one case we removed the graft due to infection 5 months after placement.
Conclusion. The midterm results of the Procol prosthesis showing a good patency and low complication rates and demonstrate that the ProCol vascular bioprosthesis is a promising material for vascular access surgery.Safety and long term results needs to be proven through controlled randomized trials.